Polypharmacy in the Elderly

Similar documents
Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING. Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz

Geriatric Pharmacology

About ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016

DEPRESCRIBING IN THE ELDERLY

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP

Polypharmacy and Polymorbid Patients: Practical Tips and Tricks

Less is More: Introduction to Deprescribing

Deprescribing Unnecessary Medications: A Four-Part Process

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Pharmaceutical Care for Geriatrics

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

Transitions of Care & Medication Reconciliation Ashley King, PharmD, BCGP Clinical Pharmacist LECOM Health March 2018

Medication Use in Older Adults

Great Low Cost in SNF-NF Jabbar Fazeli, MD Maine Medical Directors Association

Disclosure and Acknowledgements

Potentially Inappropriate Medications in Elderly Patients: Prevalence at Admission and Changes During Hospital Stay

Medication safety in vulnerable patient groups - Elderly patients -

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Presented by: Ontario s Geriatric Steering Committee

If a bad thing is happening to a patient, a drug did it until proven otherwise

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Iatrogenesis in the frail elderly

Medication Reconciliation On Admission

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

Patient Safety in Older Adults

Patient Safety in Older Adults

PAIN MANAGEMENT DISCHARGE COMMUNICATION (PM-DC) AUDIT TOOL

Polypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging

Medication Safety Presentation

Selecting the right patient for medication reviews

Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD

Polypharmacy: Making it all Work Kathy Wilson, RPh, RWSIR Director of Pharmacy

Reduction of High Risk Medications Using A Quality Initiative Perspective

Medication Management When Caring for Seniors at Home

Preventing Falls in Older Adults A Matter of Safety

Katee Kindler, PharmD, BCACP

POLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD

Public Dissemination Effective: January 2018

Update in Geriatrics: Choosing Wisely Primum Non Nocere

Meds and Falls: Keep in Step with your Meds

Prescribing Drugs to the Elderly

Perfect Endings. Home Alone. Senior Estimate. Staying Alive. Medication Madness

Integrating INTERACT into Interim Pharmacist Reviews

Navigating the Road to Efficient Medication Use

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

Anthony J. Caprio, MD, CMD, AGSF 1

Disclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults

Preventing Medication Related Falls

by Lisa Sever, BSc PHM, ACPR, CGP, RPh Learning objectives

Monitoring polypharmacy and reducing problematic prescribing

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

Conflict of interest declaration and sources of funding

Disclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships.

Stronger together - optimizing pharmacotherapy on geriatric wards?

Nurse Practitioner Practice Guideline Treatment Agreements

Objectives. What are the Beers Criteria? Mark H Beers, MD Beers Criteria: History and Utilization 5/24/2016

Reducing the risk of patient harm: A focus on opioids

A C A D E M I C D E TA I L I N G C H O O S I N G W I S E LY C O N F E R E N C E O C T 2 1, PA M M C L E A N - V E Y S E Y B S C P H A R M D R

The role of medication in falls risk

PPP 1. Continuation, modification, and discontinuation of a medication

ENHANCING MEDICATION SAFETY:

MEDICATION RECONCILIATION. Polypharmacy, use of multiple medications. and Education for Older Adults USING THE 2015 AGS BEERS CRITERIA AS A GUIDE 2.

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

Empowering Older Adults On Drug Adherence A Collaborative Service Model. Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Failure Modes Effects Analysis of Morphine Prescribing

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

Updated Beers Criteria 2012 Potentially Inappropriate Medication Use in Older Adults

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017

*GERIATRIC FELLOWSHIP COMPETENCY CHECKLIST EDUCATIONAL GOALS:

Medicines optimisation for older people with disabilities

Overview of Essentials of Pain Management. Updated 11/2016

Initiation of Clozapine Treatment Community Patients

TOP 5 DRUGS.. TO AVOID IN THE ELDERLY

Managing medicines in older people. Jane Noble and Caroline Ralph

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Outline. Disclosure. Sleep and the Elderly 1,2. Background

Polypharmacy & De-prescribing In Older Adults

LiquaFiber Clinical Trial

GERIATRICS 101. Victoria L. Braund, MD, FACP, CMD. Director, Division of Geriatrics, NorthShore Medical Director, Symphony of Evanston

Recommendations in Opioid Prescribing Guidelines for Chronic Pain

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives

Medication Management

Medication Best Practices in ALFs A four-part webinar series

Western University of Health Sciences, College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of

Medication Best Practices in ALFs A four part webinar series

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

Transcription:

Polypharmacy in the Elderly Physiotherapy Alberta Conference September 24 th 2016 Lesley Charles Associate Professor and Program Director Division of Care of the Elderly Department of Family Medicine, University of Alberta

Disclosure I have no relationship that could be perceived as placing me in a real or apparent conflict of interest in the context of this presentation.

Learning Objectives Participants will be able to: Define polypharmacy and impact Report link to adverse drug events and aware of costs, causes Review physiology of aging Apply prescribing/deprescribing criteria Review a local study looking at prevalence of polypharmacy in a geriatric OPD Consider Medication Reconciliation as a strategy for safer prescribing Become familiar in how to perform a Structured Medication Review

Polypharmacy Use of >5 medications Use of inappropriate medications or Inappropriate doses Photo Credits 5

Incidence Depending on the definition, the incidence varies from 5% to 78% 1 10% of elderly population in most developed countries spend 25-30% of total expenditures on drugs Study found the elderly use twice as many prescriptions as the young Over 65 years 12.8 prescriptions/year 35-54 years 6.7 prescriptions/year

Adverse Drug Events Inappropriate drug prescribing leads to avoidable adverse drug events (ADE) This should be considered as a cause for any new symptom in an older adult until proven otherwise 2-3 times as frequently in older persons <3 drugs: 1-2% risk of ADE >6 drugs: 13% risk of ADE

Prevalence and Impact of ADE 20% of admissions are due to ADE 35% of elderly in the community are affected by ADE 23% of discharged patients experience an adverse event (ADE 72%, therapeutic error 16%) In nursing homes $1.33 is spent on ADE for every $1 spent on medications 4-6 th leading cause of death Annual cost of drug related morbidity and mortality 76.6 billion - 1995 (USA), 177 billion - 2000

Costs of ADE 30% of admissions to hospital are because ADE ADE s increase: hospital length of stay increase costs increase mortality Annual cost of drug-related morbidity in US: $ 177 billion in 2000

Case - History 94 y o lady living alone admitted to geriatrics with falls. She has not been taking her medications PMH: macular degeneration, RA, diabetes with nephropathy, Alzheimer's dementia Meds: recent course of prednisone, celecoxib (celebrex), glyburide, donepezil (aricept), enalapril What examples of non-adherence may be happening here?

Causes of ADE in the Elderly Changes with ageing Comorbidity ADR Polypharmacy Nonadherence

Physiology of Aging Pharmacokinetics (Drug handling) 1. Absorption 2. Distribution 3. Metabolism 4. Excretion Pharmacodynamics (Effect of the Drug) 12

Summary of Age-related Changes or Slower absorption Slower metabolism Slower excretion Fat, water Sensitivity to sedatives & anticholinergics Sensitivity to catecholamines 13

Non Adherence Intentional - patient non-compliance depending on how fits with their beliefs (may be as high as 50%) Non-intentional Communication factors cognitive impairment, ineffective instructions/advice regarding the drug, complex regimens, language barrier Patient factors poor vision/hearing, limited dexterity and mobility, income Packaging factors labels, containers, generic labeling Coordination factors multiple providers, lack of social support

Non Adherence 32% of drugs ordered at discharge are not taken at all Dosing daily 74 Adherence % bid 72 tid 52 qid 53

Case Physical Exam and Ix Cachectic, VSS, disorientated Multiple bruises RA hands Pale Tender epigastrium Hb 94 MCV 70 Creatinine 154 Glucose 3-15

Case Further Information What adverse drug reactions do you think are happening and why? What other history do you want? Any further physical? Any further investigations?

Prescribing/Deprescribing Criteria are drug- or disease-oriented and have high reliability and reproducibility for prescribing/deprescribing the criteria can become outdated Consider as screening tools to identify and prioritize problem areas in drug prescribing for high-risk elderly One example: Updated 2015 Beers criteria

Beers Criteria Categorizes the medications/classes that should be avoided in those aged 65 years or more It was developed from an interdisciplinary panel of 13 experts who applied modified Delphi method to the systematic review and grading to reach consensus Medications or classes were identified and divided into three categories as per 2012

Beers Criteria Potentially inappropriate medications (PIM) or classes to avoid Medications to avoid with certain diseases/syndromes Medications to be used with caution in older adults 20

Beers Criteria Additions of drugs to avoid in the 2015 criteria include Drugs for which dose adjustment is required based on kidney function e.g., apixaban, rivoroxaban Drug drug interactions e.g., taking three or more CNS-active drugs concomitantly The table of medications with strong anticholinergic properties was updated 21

Beers Criteria Additions of drugs to avoid in the 2015 criteria include nonbenzodiazepine, benzodiazepine receptor agonist hypnotics (eszopiclone, zaleplon, zolpidem) Proton pump inhibitors beyond 8 weeks as risk of Clostridium difficile infection, bone loss, and fractures Desmopressin as risk hyponatremia 22

Screening Tools for Inappropriate Medications Beers Criteria STOPP criteria Screening Tool of Older Persons potentially inappropriate Prescriptions START Criteria Screening Tool to Alert doctors to Right Treatment Medication Appropriateness Index 23

Screening Tools for Inappropriate Medications No convincing evidence that these tools reduce morbidity, mortality or cost Use these tools with clinical judgment 24

Drug categories to avoid in the elderly, regardless of the consensus criteria used Anticholinergics Sedatives/hypnotics Anti-inflammatories Cardiovascular (e.g., some antiarrythmics, cardiac glycosides) Opiate-related analgesics Anti-infective (e.g., long-term nitrofurantoin use - pulmonary toxicity) Endocrine (e.g., testesterone, growth hormone) 25

Strategies for Appropriate Prescribing Maintain an up-to-date drug list with indications for all drugs prescribed, over the counter and herbal supplements Know the actions, adverse effects, and toxicity profiles of medications prescribed; avoid and be vigilant of high-risk drugs as identified by Beers criteria

Strategies for Appropriate Prescribing Prioritize medication prescribing consider the patient's life expectancy/prognosis/quality of life; time to benefit Start new medications at a low dose and titrate up based on tolerability and response

Strategies for Appropriate Prescribing Avoid using one drug to treat the side effects of another (e.g., prescribing cascade) Attempt to use one drug to treat two of more conditions Avoid using drugs from the same class or with similar actions Educate the patient/caregiver about each medication

Strategies for Appropriate Prescribing Maintain the simplest medication regimen regarding number of medications, routes, frequency of administration Communicate with other prescribers Engage in use of systems that support optimal prescribing behavior: drug utilization reviews pharmacist-led interventions for medication review technology and drug alert systems

Methods Design: Cross-sectional study Sample: 200 patients 65 years seen for comprehensive geriatric assessments at the Glenrose Rehabilitation Hospital in 2012-2013 Procedure: Chart review on usage of PIMs as defined by the 2012 BEERS criteria

Prevalence of PIMs Prescribed This compares with 41% using data from the Medical Expenditure Panel Survey (MEPS) in 2009 10 according to the 2012 AGS Beers Criteria Group 1:Medications to Avoid in Older Adults (regardless of diseases or conditions) Group 2: Medications Considered Potentially Inappropriate when Used in Older Adults with Certain Diseases or Syndromes

Most Common PIMs Prescribed Group 1:Medications to Avoid in Older Adults (regardless of diseases or conditions) Group 2: Medications Considered Potentially Inappropriate when Used in Older Adults with Certain Diseases or Syndromes 33

Medication Reconciliation This is a formal process designed to prevent medication errors by collection and communication of accurate patient medication history Decreases medication errors by 70% Decreases ADE by 15% Best Possible Medication History Canadian Study n 60, community hospital 60% one discrepancy 18% clinically important discrepancy 75% intercepted by medication reconciliation before patient harmed

Prescriber Pharmacy Discrepancy Code Discrepancy Info Source Home Living/Supportive Living Edmonton Zone Medication Record (Medication Reconciliation) (AFFIX CLIENT LABEL OR ADDRESSOGRAPH) Prescriber Guidelines The following Medications are currently being taken by the client. If any medications are to be discontinued or changed, notify the pharmacy by sending in a prescription. Allergies: Best Possible Medication History (BPMH) Comparison Medications that client is currently taking: include insulin, over the counter (OTC), drops, patches, creams, injections, inhalers, sprays, vitamins and herbals Dose/Route/Frequency Comments (include any discrpancies identified between BPMH and other sources and any pertinent start/stop dates) Prescriber: a. ph# Information Source Discrepancy Codes

Prescriber: a. ph# Information Source Discrepancy Codes b. ph# A Client 1. No discrepancy c. ph# B Caregiver 2. Med not currently prescribed d. ph# C Medication vials 3. Client not taking med e. ph# D Client's own med list 4. Different frequency Pharmacy: 1. ph# E Bubblepack/Dosette 5. Different route 2. ph# F NetCare PIN Profile 6. Different dose 3. ph# G Discharge info from Facility 7. OTC not taken as directed 4. ph# H Other 8. Other Medication Record sent to Prescriber Yes Prescriber: a. b. c. No Client managing medication Client refused Client following up with prescriber Other Assessor Name Assessor Signature Date

Medication Reconciliation Medication reconciliation is particularly important at transitions of care The health system currently has significant deficiencies in safety at discharge (Snow, 2009) Medication errors tend to occur in transitions of care (Desai, 2013)

MedRec as a Strategy Definition: Medication reconciliation is a formal process in which healthcare providers work together with patients, families and care providers to ensure accurate & comprehensive medication information is communicated consistently across transitions of care. (Institute of Safe Medication Practices in Canada: ISMP)

MedRec as a Strategy It has been identified by the W.H.O., as part of their High 5s project, highlighting the top 5 safety priorities internationally MedRec is an Accreditation Canada Required Organizational Practice (Accreditation Canada, 2012) It is a major safety initiative to improve communication about medications as patients transition through healthcare settings

MedRec as a Strategy It requires: a. Best Possible Medication History( BPMH): Generation of a complete and up to date medication list including drug name, dosage, route and frequency from 2 sources b. Reconciliation of the medication list and identification of discrepancies c. Documentation and communication

MedRec Online Resources Institute of Safe Medication Practices in Canada http://www.ismp-canada.org/medrec/

MedRec Online Resources Alberta Health Services Medication List Campaign http://www.albertahealthservices.ca/info/page12614.aspx

MedRec Online Resources Alberta Health Services Medication Reconciliation elearning Module http://www4.albertahealthservices.ca/elearning/wbt/medrec/index.html

STUCTURED MEDICATION REVIEW Definition: regularly scheduled discussion between a patient and their doctor/pharmacist/nurse to review ALL medications and address How each medication is working How each medication is taken Patient concerns Aim is to reduce polypharmacy, non adherence and ADR

Why to do a SMR Improves appropriate prescribing Identifies drug related problems administration, side effects and interactions Decreases Unscheduled visits No. of medications ED visits Cost Hospitalization

When to do a SMR 5 key reasons for HCP: Patients asks Take > 5 medications Have > 3 comorbidities Receive medications from > 1 MD Medication change in last 12 mo

How to do a SMR Patient brings all medications (Rx, OTC and herbals) Calculate Creatinine Clearance List all medications and indications Consider appropriate dose and frequency Identify any administration issues, side effects or drug interactions

Case 6 mo. ago 83 y o female on no meds developed L knee pain pain & insomnia Rx T#3 & lorazepam Constipation & low energy Rx senokot & paroxetine Confusion & falls Rx donepezil Now, there is confusion, falls, and constipation and five new medications Calculate creatinine clearance

Case - SMR Script Indication Appropriat Dose/Freq. Admin. Issues? S/E or Drug Interaction Action Plan Tylenol #3 2 tabs qid prn QA with L knee pain Not prn Communication Constipation, Falls, Delirium DC T#3 Tylenol qid Paroxetine 20 mg qd Depression High Communication Falls, Delirium Taper off Donepezil 10 mg qd Dementia High Communication Delirium Hold. Reassess Lorazepam 2 mg qhs Insomnia High Communication Delirium Falls Taper off. Reassess Senekot 2 tabs qhs Constipatio n OK No DC Senokot Prune Juice

Approaching a Physician/NP If you feel a medication is adversely effecting the patients therapy record your observation and temporal relationship to medication In hospital bring up at rapid rounds In community you d have to fax information to FP

Questions Contact information: Lesley.Charles@albertahealthservices.ca